News
ASUS unveils its new ROG XG Station 3 with Thunderbolt 5 connectivity: supports NVIDIA GeForce RTX 50 series, AMD Radeon RX ...
Is it too late to buy HUBS? Find out in our full research report, it’s free. Started in 2006 by two MIT grad students, HubSpot (NYSE:HUBS) is a software-as-a-service platform that helps small ...
It does not necessarily reflect the view of The Herald. PLANS for five ‘communication hubs’ in York city centre featuring digital advertising screens, free wi-fi, touchscreen maps and ...
Bristol Myers' schizophrenia drug Cobenfy stumbles as adjunctive treatment, denting blockbuster plan
Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of exclusivity, has hit a phase 3 setback. Cobenfy as an adjunctive ...
Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the efficacy and safety of Cobenfy (xanomeline and trospium chloride) as an ...
Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the efficacy and safety of Cobenfy (xanomeline and trospium chloride) as an adjunctive ...
Hosted on MSN1mon
Should illegal migrants be deported to return hubs outside the EU?The proposal includes the possibility of establishing return hubs in third countries, based on agreements concluded either bilaterally or at the European level. However, the implementation and ...
Bristol Myers Squibb’s attempt to turn Cobenfy into a megablockbuster neuroscience drug ran into a stumbling block Tuesday afternoon.
Bristol Myers Squibb will complete a full evaluation of the Phase 3 trial data and intends to present detailed results at an upcoming medical conference. Bristol Myers Squibb thanks the patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results